Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)
2023-2
PDF_2023-16-2_227-228 (Russian)

How to Cite

1.
Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Клиническая онкогематология. 2024;16(2):227-228. doi:10.21320/6nkr3a68

Keywords

Abstract

Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)  
PDF_2023-16-2_227-228 (Russian)
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.